Unlocking the Potential of Targeting the Innate Immune System

Ready to Catalyze the Next Wave of Inflammasome Therapies?
The 7th Inflammasome Therapeutics Summit is your go-to forum for drug developers, translational scientists, and immunology innovators striving to push inflammasome-targeted therapies from concept to clinic. Join 70+ leaders across pharma, biotech, and academia as they converge to decode the latest clinical readouts and explore novel therapeutic avenues beyond NLRP3.
Over three action-packed days, we will unpack high-impact case studies from the front lines – covering emerging upstream and downstream targets, mechanisms beyond canonical pathways, and how these insights are unlocking new disease areas from neuroinflammation and atopic dermatitis to obesity and fibrotic conditions.
Get ready for in-depth sessions on optimizing translational models, identifying next-gen biomarkers, and mapping inflammasome signaling across diverse indications. If you are serious about leading the charge in inflammasome drug development, this is where the future takes shape.
This industry-definitive, inflammasome-focused forum is your golden ticket to join and network with 70+ C-Levels, Vice Presidents, and Scientific Leaders across immunology, translational research, biomarker strategy, and clinical development – all under one roof – with the shared mission of advancing inflammasome-targeted therapies.
From dissecting clinical updates to identifying novel targets beyond NLRP3, this summit brings together the brightest minds transforming the field of innate immunity and inflammation.
Find out more https://ter.li/jcx1ql